Further, studies have demonstrated that the genetic deletion of CCL2 [40] and CCR2 [41] reduced the permeability of the BBB, the accumulation of immune cells in ischemic brain tissues, and subsequent cerebral infarction [42]. The gene discussed is CCL2; the disease is brain infarction.